About - IMPACT Partnership

IMPACT aims to ensure patients benefit from scientific advances sooner by making it easier for transplant centres to work together to set up clinical trials, recruit patients and share data.

Updates

AMADEUS Reaches 50% Recruitment

AMADEUS is now open at 19 UK transplant centres. To date, 197 patients have been screened and 163 patients have been randomised to receive either oral azacitidine or placebo, meaning as of September 2021 over half of the required 324 patients have been recruited to AMADEUS.

IMPACT appoints Professor Ronjon Chakraverty as Medical Director

IMPACT, the UK’s first ever clinical trials partnership dedicated to improving the outcomes for blood cancer stem cell transplant patients, has appointed Professor Ronjon Chakraverty as Medical Director.

COVID19_BMT Study Open

The IMPACT Clinical Trials Network is excited to collaborate with Dr Giovanna Lucchini at Great Ormond Street Hospital (GOSH) on a study of COVID19 infection in allogenic stem cell recipients

Call for New Clinical Trial Proposals

Call for proposals for innovative randomised clinical trials in allogeneic and autologous stem cell transplantation

Call for IMPACT Deputy Medical Director

Applications are now invited to the post of IMPACT Deputy Medical Director

BSBMT CTC – IMPACT meeting

30 delegates attended the 3rd BSBMT CTC – IMPACT meeting held in Birmingham to review new trial proposals for IMPACT.